Vitamin D Level Interpreter

What 25-OH Vitamin D Measures

The test reported on your lab result measures 25-hydroxyvitamin D — often abbreviated as 25-OH-D or 25(OH)D, and also called calcidiol. This is the principal storage form of vitamin D circulating in the bloodstream. The liver converts both the vitamin D3 produced in your skin during sun exposure and the vitamin D you absorb from food or supplements into this compound. Because 25-OH-D has a biological half-life of approximately two to three weeks, a single blood draw gives a reliable snapshot of your recent cumulative vitamin D status rather than just reflecting what you did or ate in the last few days.

The measurement differs from 1,25-dihydroxyvitamin D (calcitriol), the hormonally active form, which the kidneys produce on demand and which is tightly regulated regardless of stores. Testing calcitriol tells you little about whether your body has enough vitamin D in reserve; 25-OH-D is the correct marker for routine assessment of vitamin D status.

Reference Ranges Across Major Guidelines

The table below summarises how major health organisations classify vitamin D status. Note that exact cutoffs vary; these are the commonly cited thresholds.

Why Guidelines Disagree

The divergence between the IOM 2010 and Endocrine Society 2011 recommendations reflects a fundamental difference in scope. The IOM approached vitamin D as a public health question: what level covers the nutritional needs of 97.5% of the general healthy population for established outcomes — primarily bone mineralisation? Using randomised trial and dose-response data, they concluded that ≥20 ng/mL (50 nmol/L) was sufficient for this purpose. The Endocrine Society took a clinician's lens, asking what threshold to use when evaluating individuals who might be at risk of deficiency or deficiency-related disease, and set a more conservative clinical target of ≥30 ng/mL (75 nmol/L). Both positions had internal logic; neither was wrong for its stated purpose.

The 2024 Endocrine Society update represents a meaningful recalibration. After reviewing accumulating trial data — including large supplementation trials that largely failed to show benefit in vitamin D-replete populations — the guideline acknowledged that evidence for a single optimal target beyond preventing frank bone disease in the general population remains insufficient. The update discouraged routine testing in asymptomatic adults without risk factors, pushing back against the widespread practice of population-level screening that grew from the 2011 guideline. Clinicians still use vitamin D assessment in specific contexts (e.g., malabsorption, chronic kidney disease, osteoporosis evaluation, pregnancy), but the era of universal optimal targets may be behind us.

Causes of Low Vitamin D

Low 25-OH-D levels can arise from multiple overlapping factors:

• Limited sun exposure: Living at high latitude (above approximately 37°N), winter months, indoor work, wearing full-coverage clothing, darker skin pigmentation (which reduces UVB-driven synthesis), and habitual sunscreen use all reduce cutaneous vitamin D production.
• Low dietary intake: Few foods are rich in vitamin D naturally (fatty fish, egg yolks, liver). Fortified foods (milk, some cereals) contribute in some populations. Vegan diets without supplementation carry higher risk.
• Malabsorption conditions: Coeliac disease, inflammatory bowel disease (Crohn's, ulcerative colitis), and prior bariatric surgery all impair fat-soluble vitamin absorption, including vitamin D.
• Obesity: Vitamin D is fat-soluble and partitions into adipose tissue, reducing bioavailability in the circulation relative to body weight.
• Kidney and liver disease: The liver converts vitamin D to 25-OH-D; the kidneys convert it to the active 1,25-OH form. Disease in either organ can disrupt this pathway.
• Certain medications: Anticonvulsants (phenytoin, carbamazepine), rifampicin, and long-term glucocorticoids can accelerate the catabolism of vitamin D metabolites.

When Higher Doses Carry Risk

Vitamin D toxicity (hypervitaminosis D) is uncommon from food sources or moderate supplementation. The primary mechanism is hypercalcaemia — abnormally elevated blood calcium — which can cause nausea, weakness, kidney damage, and in severe cases cardiac arrhythmia. Toxicity typically requires sustained 25-OH-D levels above approximately 150 ng/mL (375 nmol/L), a threshold almost exclusively reached through very high-dose supplementation — generally defined as above 10,000 IU per day for prolonged periods — or prescription-strength loading doses administered without monitoring. Standard maintenance doses (400–2,000 IU/day) used by most adults pose essentially no toxicity risk. The important practical point is that levels in the "High but safe" range (60–100 ng/mL / 150–250 nmol/L) are not associated with toxicity in the literature, but also lack evidence of additional clinical benefit over levels in the sufficient range.

Related Health3 Resources